Buckley PF, Miller DD, Singer B, Arena J, Stirewalt EM.
Clinicians' recognition of the metabolic adverse effects of antipsychotic medications.
Schizophr Res
.
2005 Jun 17
;
PubMed
Abstract
These are solid studies. I wonder, though, how many of these patients are on statins to prevent atherosclerosis? Is there evidence that people with schizophrenia at risk of atherosclerosis (perhaps most of them?) are routinely given proper cardiovascular medicine?